complement 3 glomerulopathy (C3G)/immune complex membranoproliferative glomerulonephritis (IC-MPGN)

1 total trials

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

An Open-Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan in the Treatment of Post-Transplan … Ended

2024-511544-36-00 4 2021-12-21

Showing 1–1 of 1 trials